Regenxbio Inc (RGNX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: RGNX Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2024-04-17	2024-04-15	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	15,000 -3.5% 18.19 272,871 USD	15,000 -3.5%	18.19	272,871 USD
2024-03-18	2024-03-14	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	15,000 -3.5% 21.86 327,942 USD	15,000 -3.5%	21.86	327,942 USD
2024-03-07	2024-03-05	PS Planned sale	PAKOLA STEVE Chief Medical Officer Officer	12,878 -10.7% 28.36 365,220 USD	12,878 -10.7%	28.36	365,220 USD
2024-02-16	2024-02-14	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	10,348 -2.5% 16.88 174,723 USD	10,348 -2.5%	16.88	174,723 USD
2024-02-16	2024-02-14	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,652 -1.1% 16.47 76,626 USD	4,652 -1.1%	16.47	76,626 USD
2024-01-18	2024-01-16	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	45,000 -9.9% 15.18 682,992 USD	45,000 -9.9%	15.18	682,992 USD
2024-01-04	2024-01-03	PS Planned sale	PAKOLA STEVE Chief Medical Officer Officer	17,237 -13.9% 17.39 299,789 USD	17,237 -13.9%	17.39	299,789 USD
2023-12-21	2023-12-19	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	45,000 -11.2% 19.69 885,825 USD	45,000 -11.2%	19.69	885,825 USD
2023-01-05	2023-01-03	PS Planned sale	PAKOLA STEVE Chief Medical Officer Officer	3,138 -20.5% 22.17 69,559 USD	3,138 -20.5%	22.17	69,559 USD
2022-08-31	2022-08-30	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	2,400 -1.7% 30.24 72,573 USD	2,400 -1.7%	30.24	72,573 USD
2022-08-08	2022-08-05	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	17,280 -11.2% 35.19 608,035 USD	17,280 -11.2%	35.19	608,035 USD
2022-08-08	2022-08-04	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	400 -0.3% 35.00 14,000 USD	400 -0.3%	35.00	14,000 USD
2022-08-03	2022-08-01	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	2,400 -1.5% 31.26 75,012 USD	2,400 -1.5%	31.26	75,012 USD
2022-07-15	2022-07-14	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	468 -0.3% 30.00 14,040 USD	468 -0.3%	30.00	14,040 USD
2022-07-15	2022-07-13	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	4,332 -2.7% 30.01 129,988 USD	4,332 -2.7%	30.01	129,988 USD
2022-01-04	2022-01-03	PS Planned sale	PAKOLA STEVE Chief Medical Officer Officer	1,598 -16.2% 33.75 53,933 USD	1,598 -16.2%	33.75	53,933 USD
2021-11-10	2021-11-08	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 40.00 60,000 USD	1,500 -0.5%	40.00	60,000 USD
2021-09-29	2021-09-27	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 42.19 63,285 USD	1,500 -0.5%	42.19	63,285 USD
2021-06-28	2021-06-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 40.25 60,375 USD	1,500 -0.5%	40.25	60,375 USD
2021-06-28	2021-06-24	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,500 -1.6% 40.02 180,090 USD	4,500 -1.6%	40.02	180,090 USD
2021-03-01	2021-02-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 40.77 61,155 USD	1,500 -0.5%	40.77	61,155 USD
2021-02-17	2021-02-12	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	4,701 -22.3% 49.08 230,725 USD	4,701 -22.3%	49.08	230,725 USD
2021-02-10	2021-02-08	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	1,300 -7.4% 49.11 63,843 USD	1,300 -7.4%	49.11	63,843 USD
2021-02-04	2021-02-02	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	500 -3.0% 45.13 22,565 USD	500 -3.0%	45.13	22,565 USD
2021-02-04	2021-02-02	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	9,500 -36.0% 44.77 425,315 USD	9,500 -36.0%	44.77	425,315 USD
2021-01-27	2021-01-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	5,211 -1.8% 44.99 234,443 USD	5,211 -1.8%	44.99	234,443 USD
2021-01-27	2021-01-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	974 -0.3% 44.05 42,905 USD	974 -0.3%	44.05	42,905 USD
2021-01-27	2021-01-25	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	315 -0.1% 42.64 13,432 USD	315 -0.1%	42.64	13,432 USD
2021-01-20	2021-01-15	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	252 -0.2% 50.04 12,610 USD	252 -0.2%	50.04	12,610 USD
2021-01-14	2021-01-14	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	11,093 -8.9% 50.03 554,983 USD	11,093 -8.9%	50.03	554,983 USD
2021-01-14	2021-01-14	PS Planned sale	Simpson Curran Chief Oper. & Tech. Officer Officer	11,612 -39.6% 50.01 580,716 USD	11,612 -39.6%	50.01	580,716 USD
2021-01-14	2021-01-12	PS Planned sale	Simpson Curran Chief Oper. & Tech. Officer Officer	1,700 -8.7% 50.03 85,051 USD	1,700 -8.7%	50.03	85,051 USD
2021-01-14	2021-01-12	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	4,200 -3.3% 50.01 210,042 USD	4,200 -3.3%	50.01	210,042 USD
2021-01-12	2021-01-12	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	1,378 -7.8% 49.15 67,729 USD	1,378 -7.8%	49.15	67,729 USD
2021-01-12	2021-01-11	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	10,122 -38.2% 49.08 496,788 USD	10,122 -38.2%	49.08	496,788 USD
2021-01-12	2021-01-08	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	1,320 -7.5% 48.13 63,532 USD	1,320 -7.5%	48.13	63,532 USD
2021-01-12	2021-01-08	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	4,062 -18.7% 47.42 192,620 USD	4,062 -18.7%	47.42	192,620 USD
2021-01-12	2021-01-08	PS Planned sale	Christmas Patrick J. Chief Legal Officer Officer	4,618 -17.5% 46.43 214,414 USD	4,618 -17.5%	46.43	214,414 USD
2021-01-11	2021-01-08	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	573 -0.4% 48.15 27,590 USD	573 -0.4%	48.15	27,590 USD
2021-01-11	2021-01-08	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	2,208 -1.7% 47.49 104,858 USD	2,208 -1.7%	47.49	104,858 USD
2021-01-11	2021-01-08	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	2,460 -1.8% 46.45 114,267 USD	2,460 -1.8%	46.45	114,267 USD
2021-01-11	2021-01-07	PS Planned sale	Simpson Curran Chief Oper. & Tech. Officer Officer	5,185 -22.6% 50.01 259,302 USD	5,185 -22.6%	50.01	259,302 USD
2021-01-11	2021-01-07	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,500 -0.5% 50.01 75,015 USD	1,500 -0.5%	50.01	75,015 USD
2021-01-11	2021-01-07	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	10,998 -7.6% 50.00 549,900 USD	10,998 -7.6%	50.00	549,900 USD
2020-12-30	2020-12-28	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	1,853 -0.8% 49.16 91,093 USD	1,853 -0.8%	49.16	91,093 USD
2020-12-30	2020-12-28	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,647 -1.9% 48.47 225,240 USD	4,647 -1.9%	48.47	225,240 USD
2020-12-28	2020-12-24	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	3,376 -2.5% 50.00 168,800 USD	3,376 -2.5%	50.00	168,800 USD
2020-12-28	2020-12-23	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,500 -1.8% 50.00 225,000 USD	4,500 -1.8%	50.00	225,000 USD
2020-12-28	2020-12-23	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	21,124 -13.4% 50.01 1,056,411 USD	21,124 -13.4%	50.01	1,056,411 USD
2020-12-18	2020-12-16	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	15,000 -5.9% 45.00 675,000 USD	15,000 -5.9%	45.00	675,000 USD
2020-12-14	2020-12-11	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	14,916 -8.6% 40.17 599,176 USD	14,916 -8.6%	40.17	599,176 USD
2020-12-14	2020-12-10	PS Planned sale	Mills Kenneth T. President and CEO Executive Director	4,500 -1.8% 40.00 180,000 USD	4,500 -1.8%	40.00	180,000 USD
2020-12-14	2020-12-10	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	22,584 -11.6% 40.06 904,715 USD	22,584 -11.6%	40.06	904,715 USD
2020-07-17	2020-07-15	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	14,950 -7.1% 40.10 599,495 USD	14,950 -7.1%	40.10	599,495 USD
2020-05-12	2020-05-11	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	500 -0.2% 40.00 20,000 USD	500 -0.2%	40.00	20,000 USD
2020-05-12	2020-05-08	PS Planned sale	Vasista Vittal Chief Financial Officer Officer	7,000 -3.3% 40.18 281,260 USD	7,000 -3.3%	40.18	281,260 USD
2020-04-27	2020-04-24	PS Planned sale	Vasista Vittal Chief Financial Officer	12,000 -5.4% 40.11 481,320 USD	12,000 -5.4%	40.11	481,320 USD
2020-04-27	2020-04-23	PS Planned sale	Vasista Vittal Chief Financial Officer	3,000 -1.3% 40.00 120,000 USD	3,000 -1.3%	40.00	120,000 USD
2020-02-12	2020-02-11	PS Planned sale	Simpson Curran SVP, Product Development & CTO	3,692 -48.3% 51.37 189,658 USD	3,692 -48.3%	51.37	189,658 USD
2020-02-12	2020-02-11	PS Planned sale	Simpson Curran SVP, Product Development & CTO	8,872 -53.7% 50.13 444,753 USD	8,872 -53.7%	50.13	444,753 USD
2020-02-12	2020-02-10	PS Planned sale	HAYDEN DONALD J JR	24,800 -100.0% 50.11 1,242,728 USD	24,800 -100.0%	50.11	1,242,728 USD
2020-02-12	2020-02-10	PS Planned sale	Vasista Vittal Chief Financial Officer	14,129 -6.3% 50.12 708,145 USD	14,129 -6.3%	50.12	708,145 USD
2020-02-12	2020-02-10	PS Planned sale	Vasista Vittal Chief Financial Officer	677 -0.3% 49.05 33,207 USD	677 -0.3%	49.05	33,207 USD
2020-02-12	2020-02-10	PS Planned sale	Simpson Curran SVP, Product Development & CTO	44,429 -81.8% 50.22 2,231,224 USD	44,429 -81.8%	50.22	2,231,224 USD
2020-02-07	2020-02-05	PS Planned sale	HAYDEN DONALD J JR	2,000 -100.0% 50.00 100,000 USD	2,000 -100.0%	50.00	100,000 USD
2020-02-07	2020-02-05	PS Planned sale	Vasista Vittal Chief Financial Officer	300 -0.1% 50.00 15,000 USD	300 -0.1%	50.00	15,000 USD
2020-02-07	2020-02-05	PS Planned sale	Simpson Curran SVP, Product Development & CTO	5,637 -19.9% 50.00 281,850 USD	5,637 -19.9%	50.00	281,850 USD
2020-01-21	2020-01-17	PS Planned sale	HAYDEN DONALD J JR	3,200 -100.0% 50.01 160,032 USD	3,200 -100.0%	50.01	160,032 USD
2020-01-21	2020-01-17	PS Planned sale	Simpson Curran SVP, Product Development & CTO	5,922 -20.4% 50.00 296,100 USD	5,922 -20.4%	50.00	296,100 USD
2020-01-21	2020-01-17	PS Planned sale	Vasista Vittal Chief Financial Officer	2,394 -1.1% 50.00 119,700 USD	2,394 -1.1%	50.00	119,700 USD
2020-01-16	2020-01-14	PS Planned sale	HAYDEN DONALD J JR	30,000 -100.0% 45.60 1,368,000 USD	30,000 -100.0%	45.60	1,368,000 USD
2020-01-10	2020-01-08	PS Planned sale	Vasista Vittal Chief Financial Officer	5,100 -2.2% 41.92 213,792 USD	5,100 -2.2%	41.92	213,792 USD
2020-01-10	2020-01-08	PS Planned sale	Vasista Vittal Chief Financial Officer	2,400 -1.0% 41.40 99,360 USD	2,400 -1.0%	41.40	99,360 USD
2019-12-11	2019-12-09	S Sale	Simpson Curran SVP, Product Development & CTO	6,153 -20.4% 44.26 272,332 USD	6,153 -20.4%	44.26	272,332 USD
2019-12-11	2019-12-09	S Sale	Simpson Curran SVP, Product Development & CTO	9,399 -23.8% 43.40 407,917 USD	9,399 -23.8%	43.40	407,917 USD